MedTrace Logo

Prevalence of Post-traumatic Stress Disorder and Trauma Symptoms in a General Population Sample

NCT05679245 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2023-11-18

No results posted yet for this study

Summary

The goal of this observational study is to learn about how many people have post-traumatic stress disorder and related symptoms in the general population of people without any mental illness in the Barcelona region of Catalonia, Spain. The main questions it aims to answer are:

* What is the prevalence of post-traumatic stress disorder in a sample of healthy controls without other mental disorders?
* What is the prevalence of trauma-related symptoms in a sample of healthy controls without mental illness?
* What is the prevalence of dissociative symptoms (including symptoms of depersonalisation and somatoform dissociation) in a sample of healthy controls without mental illness?
* What is the prevalence of recent and childhood traumatic life events in a sample of healthy controls without mental illness?
* What is the prevalence of difficulties in psychosocial functioning in healthy controls without mental illness?
* What is the prevalence of depressive symptoms in healthy controls without mental illness?
* What is the prevalence of general psychiatric symptoms in healthy controls without mental illness? Participants will be asked to take part in an online screening programme, and then to come to an interview with a clinician who will apply validated scales to test the above.

Conditions

  • Post-traumatic Stress Disorder
  • Psychological Trauma

Interventions

DIAGNOSTIC_TEST

Assessment for exposure to psychological trauma and related symptoms

To be assessed for exposure to traumatic life events, post-traumatic stress disorder, trauma-related symptoms, dissociative symptoms, affective symptoms, and psychosocial functioning.

Sponsors & Collaborators

  • Parc de Salut Mar

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-28
Primary Completion
2024-03-31
Completion
2024-03-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05679245 on ClinicalTrials.gov